REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that with the support of the American College of
Gynesonics to announce completion of latest funding round soon, new CEO says
Originally published by Mergermarket 25 Oct 2023 17:55 EDT Gynesonics, a Redwood City, California-based women’s healthcare and medical device company, plans to announce the completion of a significant financing round soon, said new CEO Skip Baldino. The company announced a USD 25m financing
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United
SSM Medical Minute on Fox 2 News Talks Uterine Fibroid Treatment with Sonata TFA
Dr. Brigid Holleran-Schwartz of SSM Health, talks with Fox 2 News in St. Louis, MO. about the Sonata Treatment. The Sonata Treatment is an incisionless solution clinically proven to reduce fibroid symptoms including heavy menstrual bleeding. This treatment can address a wide range of fibroid types
Stony Brook Medicine’s Patient Shares How Sonata Improved Her Quality of Life
Donna Febo, a patient of Stony Brook Medicine in New York, thought her heavy bleeding and pelvic pain were caused by her body approaching menopause. After talking with Dr. Conway, they were able to identify two fibroids to be the likely culprits causing her symptoms. Dr. Conway suggested the Sonata
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids is Now Covered by UnitedHealthcare
REDWOOD CITY, CA, August 1, 2023 – Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure is now covered by UnitedHealthcare, effective August 1, 2023.
Novant Health highlights Sonata TFA technology that destroys fibroids and preserves normal uterine tissue
The Sonata System is an effective method of treating uterine fibroids using radiofrequency ablation (RFA). Sonata is an incisionless procedure that uses a handpiece with a radiofrequency tip that targets and treats fibroids from within the uterus while preserving healthy uterine tissue. Read
Holland Hospital Talks About the Sonata Treatment with WoodTV for Fibroid Awareness Month
July is Fibroid Awareness Month. Fibroids are non-cancerous tumors that grow in and around the uterus and have the potential to cause a variety of symptoms including heavy menstrual bleeding. To spread awareness relief from symptomatic fibroids, Dr. Jim Gerard, an OB-GYN at Holland Hospital, spoke